Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
Dr. Reddy's has the rights to distribute 250mn doses in India
India sales grew 23.5% YoY with consolidation of Wockhardt products
Textile chemicals and animal health and nutrition (AHN) bounced back with growth of 30% and 41% YoY
Recognition for service innovation to enhance customer experience
Both companies have decided not to pursue their interest for SICIT Group S.p.A. and to abandon the intention to launch a voluntary tender offer over SICIT Group's shares pursuant to articles 102 and 106, fourth paragraph, of the Italian Financial Act
The deal is expected to close in second-quarter 2021
The project will utilize approximately 70 MW of renewable power and will create the starting point for locally produced Kenyan fertilizer
The company has donated 20 units of advanced German Ventilators worth approximately Rs. 1.9 crores to nine hospitals
A Memorandum of Understanding has been signed between SUEZ, Veolia, and the Consortium of investors composed of Meridiam–GIP–CDC/CNP with a view to creating a new SUEZ with revenues of nearly €7 billion
This acquisition of Duraziv will allow Saint-Gobain to expand its range of interior and exterior finishing solutions
A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021
MCFL reported total income of Rs.567.82 crores during the period ended March 31, 2020.
The company posted net profit of Rs.47.99 crores for the FY ended March 31, 2021
The company has posted net loss of Rs. 6.12 crores for the period ended March 31, 2020.
Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
Financial support is being provided as a grant from the Government of India
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
